PH22020050168Y1 - Process for isolating and producing antibodies for the prevention and treatment of covid-19 and related diseases from blood plasma containing said antibodies - Google Patents

Process for isolating and producing antibodies for the prevention and treatment of covid-19 and related diseases from blood plasma containing said antibodies

Info

Publication number
PH22020050168Y1
PH22020050168Y1 PH22020050168U PH22020050168U PH22020050168Y1 PH 22020050168 Y1 PH22020050168 Y1 PH 22020050168Y1 PH 22020050168 U PH22020050168 U PH 22020050168U PH 22020050168 U PH22020050168 U PH 22020050168U PH 22020050168 Y1 PH22020050168 Y1 PH 22020050168Y1
Authority
PH
Philippines
Prior art keywords
antibodies
blood plasma
covid
isolating
prevention
Prior art date
Application number
PH22020050168U
Other versions
PH22020050168U1 (en
Inventor
Danilo P Manayaga
Original Assignee
Island Tech Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Island Tech Systems Corp filed Critical Island Tech Systems Corp
Priority to PH22020050168U priority Critical patent/PH22020050168U1/en
Publication of PH22020050168Y1 publication Critical patent/PH22020050168Y1/en
Publication of PH22020050168U1 publication Critical patent/PH22020050168U1/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present utility model is directed to a novel process for isolating and producing antibodies from blood plasma containing said antibodies. The present utility model provides for the isolation and production of antibodies from blood plasma from screened and tested donor patients, preferably those who are positively tested for or those who have successfully recovered from the coronavirus 2019 disease (COVID-19). The process generally comprises extracting blood plasma from screened and qualified donors, and then subjecting the blood plasma into plasma fractionation and purification procedures to produce the desired antibodies. The isolated and purified antibodies are obtained in suitable pharmaceutical formulation, preferably into intravenous (IV) form, and are administered to subjects in need thereof for the prevention and treatment of COVID-19 and related diseases.
PH22020050168U 2020-05-26 2020-05-26 Process for isolating and producing antibodies for the prevention and treatment of covid-19 and related diseases from blood plasma containing said antibodies PH22020050168U1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PH22020050168U PH22020050168U1 (en) 2020-05-26 2020-05-26 Process for isolating and producing antibodies for the prevention and treatment of covid-19 and related diseases from blood plasma containing said antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PH22020050168U PH22020050168U1 (en) 2020-05-26 2020-05-26 Process for isolating and producing antibodies for the prevention and treatment of covid-19 and related diseases from blood plasma containing said antibodies

Publications (2)

Publication Number Publication Date
PH22020050168Y1 true PH22020050168Y1 (en) 2021-01-27
PH22020050168U1 PH22020050168U1 (en) 2021-01-27

Family

ID=74212978

Family Applications (1)

Application Number Title Priority Date Filing Date
PH22020050168U PH22020050168U1 (en) 2020-05-26 2020-05-26 Process for isolating and producing antibodies for the prevention and treatment of covid-19 and related diseases from blood plasma containing said antibodies

Country Status (1)

Country Link
PH (1) PH22020050168U1 (en)

Also Published As

Publication number Publication date
PH22020050168U1 (en) 2021-01-27

Similar Documents

Publication Publication Date Title
CN101618050B (en) Compound fungus polysaccharide with function of enhancing immunity and application thereof
CN101669960B (en) Akebiasaponin D and application of composition thereof in preparation of medicaments for treating senile dementia
CN110237232A (en) Radix pseudostellariae cyclic peptides B is improving the application in memory and/or senile dementia prevention and cure
AU2021469614A1 (en) Use of composition comprising astilbin and/or isomer thereof in preparation of drug for treating psoriasis
CN117679519A (en) Pharmaceutical composition for preventing and treating acute facial paralysis and application thereof
CN113679737A (en) Application of mesenchymal stem cells in prevention and treatment of adult depression
PH22020050168Y1 (en) Process for isolating and producing antibodies for the prevention and treatment of covid-19 and related diseases from blood plasma containing said antibodies
CN101152208A (en) Application of brown seaweed polyoses sulfate in preparing medicament for treating senile dementia
CN112641777A (en) Application of ergothioneine substances in preparation of medicine for preventing and treating cerebral arterial thrombosis
CN105796587B (en) Caulis bambusae in taenian polysaccharide immunological regulation, it is antitumor in application
CN101703497A (en) Application of Chlorogenic acid in preparing drug having protection and restoration functions on spleen hematopoietic stem cell injuries
CN108904536A (en) Application of the endothelial progenitor cells in the cerebral arterial thrombosis drug of preparation treatment convalescence and/or sequela stage
CN109260214A (en) Application of the paeoniflorin compound in preparation treatment medication for treating pyemia
PH22020050169U1 (en) Intravenous pharmaceutical form of isolated and purified antibodies for the prevention and treatment of covid-19 and related diseases
CN108261539A (en) A kind of composition, preparation method and the usage for antithrombotic
CN113264946A (en) Dihydroartemisinin derivative and application thereof in preparation of drugs for treating and preventing cerebrovascular diseases
CN101695485B (en) Use of chlorogenic acid in preparing medicament for treating thrombocytopenia and anemia
CN114980882A (en) Synergistic combination of cannabinoid and lycopene anti-inflammatory
Hermankova et al. The identification of interferon-γ as a key supportive factor for retinal differentiation of murine mesenchymal stem cells
TW201619390A (en) Method for preparing seaweed-oligosaccharide with anticoagulant activity
CN116196352B (en) Compound essential oil with effects of inducing resuscitation and refreshing mind and preparation method and application thereof
CN116920069B (en) Traditional Chinese medicine extract and application thereof in promoting umbilical cord stem cells to secrete VEGF
CN112245433B (en) Application of ectoine substances in preparation of medicine for preventing and treating cerebral arterial thrombosis
CN106676070A (en) In-vitro oxygen-glucose deprivation model establishment method
EP1180036B1 (en) Cell therapy for chronic stroke